The epidemiology of dengue outbreaks in 2016 and 2017 in Ouagadougou, Burkina Faso.
Burkina Faso
Dengue
Epidemiology
Infectious disease
Outbreak
Public health
Serotypes
Viral disease
Viruses
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
13
06
2019
revised:
27
10
2019
accepted:
30
06
2020
entrez:
23
7
2020
pubmed:
23
7
2020
medline:
23
7
2020
Statut:
epublish
Résumé
Dengue is prevalent in as many as 128 countries with more than 100 million clinical episodes reported annually and four billion people estimated to be at risk. While dengue fever is systematically diagnosed in large parts of Asia and South America, the disease burden in Africa is less well investigated. This report describes two consecutive dengue outbreaks in Ouagadougou, Burkina Faso in 2016 and 2017. Blood samples of febrile patients received at Schiphra laboratory in Ouagadougou, Burkina Faso, were screened for dengue infection using SD Bioline Dengue Duo rapid diagnostic test kits (Standard Diagnostics, Suwon, Republic of Korea). A total of 1,397 and 1,882 cases were reported by a single laboratory in 2016 and 2017, respectively. Most cases were at least 15 years of age and the results corroborated reports from WHO indicating the circulation of three dengue virus serotypes in Burkina Faso. This study complements data from other, simultaneously conducted surveillance efforts, and indicates that the dengue disease burden might be underestimated in sub-Saharan African nations. Dengue surveillance should be enhanced in African settings to determine the burden more accurately, and accelerated efforts towards a dengue vaccine should be put in place.
Sections du résumé
BACKGROUND
BACKGROUND
Dengue is prevalent in as many as 128 countries with more than 100 million clinical episodes reported annually and four billion people estimated to be at risk. While dengue fever is systematically diagnosed in large parts of Asia and South America, the disease burden in Africa is less well investigated. This report describes two consecutive dengue outbreaks in Ouagadougou, Burkina Faso in 2016 and 2017.
METHODS
METHODS
Blood samples of febrile patients received at Schiphra laboratory in Ouagadougou, Burkina Faso, were screened for dengue infection using SD Bioline Dengue Duo rapid diagnostic test kits (Standard Diagnostics, Suwon, Republic of Korea).
RESULTS
RESULTS
A total of 1,397 and 1,882 cases were reported by a single laboratory in 2016 and 2017, respectively. Most cases were at least 15 years of age and the results corroborated reports from WHO indicating the circulation of three dengue virus serotypes in Burkina Faso.
CONCLUSION
CONCLUSIONS
This study complements data from other, simultaneously conducted surveillance efforts, and indicates that the dengue disease burden might be underestimated in sub-Saharan African nations. Dengue surveillance should be enhanced in African settings to determine the burden more accurately, and accelerated efforts towards a dengue vaccine should be put in place.
Identifiants
pubmed: 32695907
doi: 10.1016/j.heliyon.2020.e04389
pii: S2405-8440(20)31233-0
pii: e04389
pmc: PMC7364030
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e04389Informations de copyright
© 2020 The Authors.
Références
PLoS One. 2014 Mar 19;9(3):e90037
pubmed: 24646519
PLoS One. 2019 Mar 6;14(3):e0213301
pubmed: 30840708
Emerg Infect Dis. 2011 Aug;17(8):1349-54
pubmed: 21801609
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
PLoS Negl Trop Dis. 2012;6(8):e1760
pubmed: 22880140
Rev Med Virol. 2016 May;26(3):183-96
pubmed: 26922851
Am J Trop Med Hyg. 2009 Oct;81(4):645-50
pubmed: 19815880
PLoS Negl Trop Dis. 2019 Dec 6;13(12):e0007882
pubmed: 31809504
Lancet Infect Dis. 2016 Jun;16(6):712-723
pubmed: 26874619
Paediatr Int Child Health. 2012 May;32 Suppl 1:18-21
pubmed: 22668445
Sci Data. 2014 May 27;1:140004
pubmed: 25977762
Am J Trop Med Hyg. 2000 Mar;62(3):378-83
pubmed: 11037781